
Medicinal Cannabis Treatments
Source: Mechoulam, R., & Parker, L. A. (2013). The Endocannabinoid System and the Brain. Annual Review of Psychology, 64, 21-47.
Appetite Stimulation
Cannabis has been shown to stimulate appetite in patients with HIV/AIDS and cancer, as supported by studies like a systematic review published in the American Journal of Hospice and Palliative Medicine.
One notable study examining the effects of medicinal cannabis on appetite stimulation was published in the journal "Current Opinion in Clinical Nutrition and Metabolic Care" in 2011.
This study reviewed the existing literature on the use of cannabinoids, particularly delta-9-tetrahydrocannabinol (THC), for appetite stimulation in patients with various medical conditions.
Here are some key findings from the study:
Appetite Stimulation
The study found that cannabinoids, particularly THC, have a well-established appetite-stimulating effect, often referred to as "the munchies." THC acts on cannabinoid receptors in the brain and peripheral tissues, increasing the desire for food and enhancing the pleasure associated with eating.
Clinical Applications
Cannabinoids have been studied for their appetite-stimulating effects in patients with conditions associated with reduced appetite and weight loss, such as cancer, HIV/AIDS, and cachexia (wasting syndrome).
Several clinical trials have demonstrated the efficacy of cannabinoids in increasing food intake and body weight in these patient populations.
Dose-Dependent Response
The appetite-stimulating effects of cannabinoids appear to be dose-dependent, with higher doses of THC producing greater increases in appetite. However, higher doses may also be associated with an increased risk of adverse effects, such as sedation, cognitive impairment, and psychoactive effects.
Safety and Tolerability
While cannabinoids are generally well-tolerated, their use for appetite stimulation should be carefully monitored, particularly in patients with pre-existing psychiatric conditions or substance use disorders.
Long-term use of cannabinoids may also be associated with tolerance and dependence, although the risk is generally considered low.